Increases in renal replacement therapy in Australia and New Zealand: Understanding trends in diabetic nephropathy

Nephrology

Volumn 17, Issue 1, 2012, Pages 76-84

  Grace, Blair S ^a   Clayton, Philip ^a,b   McDonald, Stephen P ^a,c  

^a ROYAL ADELAIDE HOSPITAL   (Australia)

^b ROYAL PRINCE ALFRED HOSPITAL   (Australia)

^c UNIVERSITY OF ADELAIDE   (Australia)

Author keywords

Aboriginal; end stage renal disease; gender; incidence trends; M ori; Pacific Islander; Torres Strait Islanders

Indexed keywords

ABORIGINE; ADOLESCENT; ADULT; ARTICLE; AUSTRALIA; CHILD; COMORBIDITY; DIABETIC NEPHROPATHY; FEMALE; GROUPS BY AGE; HIGH RISK POPULATION; HUMAN; INCIDENCE; INFANT; INSULIN DEPENDENT DIABETES MELLITUS; KIDNEY FAILURE; MAJOR CLINICAL STUDY; MALE; MAORI; NEW ZEALAND; NEWBORN; NON INSULIN DEPENDENT DIABETES MELLITUS; PACIFIC ISLANDER; PRESCHOOL CHILD; PRIORITY JOURNAL; REGISTER; RENAL REPLACEMENT THERAPY; RISK ASSESSMENT; SCHOOL CHILD; SEX DIFFERENCE; TREND STUDY;

AGE FACTORS; AGED, 80 AND OVER; AUSTRALIA; COMORBIDITY; DIABETIC NEPHROPATHIES; FEMALE; GLOMERULAR FILTRATION RATE; HEALTH SERVICES, INDIGENOUS; HEALTH TRANSITION; HUMANS; INFANT, NEWBORN; KIDNEY FAILURE, CHRONIC; MALE; NEW ZEALAND; REGISTRIES; RENAL REPLACEMENT THERAPY; RISK FACTORS; SEX FACTORS; YOUNG ADULT;

EID: 84855174112     PISSN: 13205358     EISSN: 14401797     Source Type: Journal    
DOI: 10.1111/j.1440-1797.2011.01512.x     Document Type: Article

References (43)

1. Dyck R,. Mechanisms of renal disease in indigenous populations: Influences at work in Canadian indigenous peoples. Nephrology 2001; 6: 3-7. (Pubitemid 32299574)
2. Stewart JH, McCredie MRE, McDonald SP,. The incidence of treated end-stage renal disease in New Zealand Maori and Pacific Island people and in indigenous Australians. Nephrol. Dial. Transplant. 2004; 19: 678-85. (Pubitemid 38263130)
3. Hoy W, Vanbuynder P, Mathews JD, et al,. Renal disease and the environment: Lessons from Aboriginal Australia. Nephrology 2001; 6: 19-24. (Pubitemid 32299576)
4. Zimmet P, Alberti K, Shaw J,. Global and societal implications of the diabetes epidemic. Nature 2001; 414: 782-7. (Pubitemid 34000780)
5. Stewart JH, McCredie MR, Williams SM, et al,. Interpreting incidence trends for treated end-stage renal disease: Implications for evaluating disease control in Australia. Nephrology 2004; 9: 238-46. (Pubitemid 39318648)
6. Tao BT, Taylor DG,. Economics of Type 1 Diabetes. Endocrinol. Metabol. Clin. North Am. 2010; 39: 499-512.
7. Levey AS, Bosch JP, Lewis JB, et al,. A more accurate method to estimate glomerular filtration rate from serum creatinine: A new prediction equation. Modification of Diet in Renal Disease Study Group. Ann. Intern. Med. 1999; 130: 461-70. (Pubitemid 29135798)
8. Australian Bureau of Statistics. Population by Age and Sex, Australian States and Territories. ABS Catalogue number 3201.0. Canberra: Australian Bureau of Statistics, 2009.
9. Australian Bureau of Statistics. Experimental Estimates and Projections, Aboriginal and Torres Strait Islander Australians, 1991 to 2021. Catalogue number 3238.0. Canberra: Australian Bureau of Statistics, 2009.
10. Statistics New Zealand. Mäori Population Estimates: Mean Year Ended 31 December 1991-2009. Auckland: Statistics New Zealand, 2010.
11. Statistics New Zealand. Estimated Total Population by Sex, Year Ended 31 December (1926-2009) and 30 June (1937-2009). Auckland: Statistics New Zealand, 2010.
12. Statistics New Zealand. Estimated National Ethnic Population by Age and Sex at 30 June 1996, 2001 and 2006. Auckland: Statistics New Zealand, 2010.
13. Williams RL,. A note on robust variance estimation for cluster-correlated data. Biometrics 2000; 56: 645-6. (Pubitemid 30422662)
14. Australian Bureau of Statistics. Deaths, Summary, States and Territories-1999 to 2009. ABS Catalogue number 3302.1. Canberra: Australian Bureau of Statistics, 2010.
15. Dunstan DW, Zimmet PZ, Welborn TA, et al,. The rising prevalence of diabetes and impaired glucose tolerance-The Australian diabetes, obesity and lifestyle study. Diabetes Care 2002; 25: 829-34. (Pubitemid 41094278)
16. Trewin D, Madden R,. The Health and Welfare of Australia's Aboriginal and Torres Strait Islander Peoples 2005. Australian Institute of Health and Welfare Cat. No. IHW14, and Australian Bureau of Statistics Cat. No. 4704.0. 2005.
17. Penm E,. Cardiovascular Disease and Its Associated Risk Factors in Aboriginal and Torres Strait Islander Peoples 2004-05. Cardiovascular disease series no. 29. Cat. no. CVD 41. Canberra: AIHW, 2008.
18. Wang ZQ, Hoy WE, Si DM,. Incidence of type 2 diabetes in Aboriginal Australians: An 11-year prospective cohort study. BMC Public Health 2010; 10: 1-5.
19. Australian Bureau of Statistics. National Aboriginal and Torres Strait Islander Survey 1994. ABS 4190.0. Canberra; 1994.
20. Trewin D,. National Health Survey: Aboriginal and Torres Strait Islander results, Australia. ABS 4715.0. Canberra; 2001.
21. Australian Bureau of Statistics. National Aboriginal and Torres Strait Islander Health Survey: Australia, 2004-05. Canberra: Australian Bureau of Statistics, 2006.
22. Barr ELM, Magliano DJ, Zimmet PZ, et al,. AusDiab 2005: The Australian Diabetes, Obesity and Lifestyle Study. Melbourne: International Diabetes Institute, Melbourne, Australia, 2006.
23. Dunstan D, Zimmet P, Welborn T, et al,. Diabetes and Associated Disorders in Australia, 2000: The Accelerating Epidemic. Australian Diabetes, Obesity & Lifestyle Study (AusDiab). Melbourne: International Diabetes Institute, 2001.
24. Ellison TL, Elliott R, Moyes SA,. HbA(1C) screening for undiagnosed diabetes in New Zealand. Diabetes-Metab. Res. Rev. 2005; 21: 65-70. (Pubitemid 40163975)
25. Phillips CB, Patel MS, Weeramanthri TS,. High mortality from renal disease and infection in Aboriginal central Australians with diabetes. Aust. J. Public Health 1995; 19: 482-6. (Pubitemid 26032007)
26. Villar E, Polkinghorne K, Chang S, et al,. Effect of type 2 diabetes on mortality risk associated with end-stage kidney disease. Diabetologia 2009; 52: 2536-41.
27. Beaglehole R, Stewart AW, Jackson R, et al,. Declining rates of coronary heart disease in New Zealand and Australia, 1983-1993. Am. J. Epidemiol. 1997; 145: 707-13.
28. Joshy G, Dunn P, Fisher M, et al,. Ethnic differences in the natural progression of nephropathy among diabetes patients in New Zealand: Hospital admission rate for renal complications, and incidence of end-stage renal disease and renal death. Diabetologia 2009; 52: 1474-8.
29. Sundborn G, Metcalf P, Scragg R, et al,. Ethnic differences in the prevalence of new and known diabetes mellitus, impaired glucose tolerance, and impaired fasting glucose. Diabetes Heart and Health Survey (DHAH) 2002-2003, Auckland New Zealand. N. Z. Med. J. 2007; 120: 1-12.
30. Kenealy TW, Eggleton KS, Robinson EM, et al,. Systematic care to reduce ethnic disparities in diabetes care. Diabetes Res. Clin. Pract. 2010; 89: 256-61.
31. Hoy W,. Renal disease in Australian aborigines. Nephrol. Dial. Transplant. 2000; 15: 1293-7.
32. Silbiger S, Neugarten J,. Gender and human chronic renal disease. Gend. Med. 2008; 5: S3-10. (Pubitemid 351455227)
33. Chang SH, Mathew TH, McDonald SP,. Analgesic nephropathy and renal replacement therapy in Australia: Trends, comorbidities and outcomes. Clin. J. Am. Soc. Nephrol. 2008; 3: 768-76.
34. Marley JV, Dent H, Wearne M, et al,. Haemodialysis outcomes of Aboriginal and Torres Strait Islander patients of remote Kimberley region origin. Med. J. Aust. 2010; 139: 516-20.
35. McDonald S, McCredie M, Williams S, et al,. Factors influencing reported rates of treated end-stage renal disease. Adv. Chronic Kidney Dis. 2005; 12: 32-8. (Pubitemid 40255601)
36. Cooper BA, Branley P, Bulfone L, et al,. A randomized, controlled trial of early versus late initiation of dialysis. N. Engl. J. Med. 2010; 363: 609-19.
37. United States Renal Data System. Annual Data Report 2010. Bethesda, MD: National Institute of Health, National Institute of Diabetes and Digestive and Kidney Diseases, 2010.
38. Canadian Organ Replacement Register. Annual Report: Treatment of End-Stage Organ Failure in Canada, 2000 to 2009. Ontario: Canadian Institute for Health Education, 2011.
39. Kramer A, Stel V, Zoccali C, et al,. An update on renal replacement therapy in Europe: ERA-EDTA Registry data from 1997 to 2006. Nephrol. Dial. Transplant. 2009; 24: 3557-66.
40. Caskey FJ, Schober-Halstenberg HJ, Roderick PJ, et al,. Exploring the differences in epidemiology of treated ESRD between Germany and England and Wales. Am. J. Kidney Dis. 2006; 47: 445-54. (Pubitemid 43255178)
41. National Diabetes Surveillance System. Diabetes in Canada, 2009. Ottawa: Public Health Agency of Canada, 2009.
42. Centres for Disease Control and Prevention. Crude and Age-Adjusted Percentage of Civilian, Noninstitutionalized Population with Diagnosed Diabetes, United States, 1980-2009. 2011 [updated 2011; cited 5 Jun 2011.]; Available from URL
43. Byrne C, Ford D, Gilg J, et al,. UK ESRD Incident Rates in 2008: National and Centre-Specific Analyses. UK Renal Registry: The Twelfth Annual Report. Bristol: UK Renal Registry, 2009.